Nuzenio

Advances Phase

Advances Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Definium Therapeutics (NASDAQ: DFTX) grows cash to $1.1B, Q2 loss deepens - Stock TitanStock Titan · Thu, 06 Aug 2026 20:11:54 GMTAgenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 11:30:00 GMTPentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program - TradingViewTradingView · Thu, 06 Aug 2026 06:00:00 GMTAgenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer - BitgetBitget · Thu, 06 Aug 2026 03:53:29 GMTVaxcyte (PCVX) Advances Phase 3 Trials Amid Mixed Market Signals - GuruFocusGuruFocus · Wed, 05 Aug 2026 23:19:50 GMTAlan Bryce, MD, highlights key phase 3 advances in prostate cancer - Urology TimesUrology Times · Tue, 04 Aug 2026 17:02:54 GMTTallahassee advances phase 3 of Centerville Road electric project, eyes phase 4 - fox49.tvfox49.tv · Thu, 30 Jul 2026 12:13:58 GMTStartup advances novel oral Type 1 diabetes therapy to next phase of human testing - The University of Alabama at BirminghamThe University of Alabama at Birmingham · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:11:54 GMTDefinium Therapeutics (NASDAQ: DFTX) grows cash to $1.1B, Q2 loss deepens - Stock Titan
Thu, 06 Aug 2026 11:30:00 GMTAgenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - Yahoo Finance UK
Thu, 06 Aug 2026 06:00:00 GMTPentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program - TradingView
Thu, 06 Aug 2026 03:53:29 GMTAgenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer - Bitget
Wed, 05 Aug 2026 23:19:50 GMTVaxcyte (PCVX) Advances Phase 3 Trials Amid Mixed Market Signals - GuruFocus
Tue, 04 Aug 2026 17:02:54 GMTAlan Bryce, MD, highlights key phase 3 advances in prostate cancer - Urology Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advances Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.